Cargando…
Acute Respiratory Distress Syndrome after Treatment of Metastatic Prostate Cancer with Taxotere: A Case Report and Literature Review
Prostate cancer is the most common cancer in men. Docetaxel is a common chemotherapeutic agent that has proven its efficacy in the treatment of patients with both castration sensitive and resistant metastatic prostate cancer. We report a case of acute respiratory distress syndrome (ARDS) in a patien...
Autores principales: | Raufi, Ali, Dotson, Jennifer, Khasawneh, Mohamad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550759/ https://www.ncbi.nlm.nih.gov/pubmed/26351611 http://dx.doi.org/10.1155/2015/198381 |
Ejemplares similares
-
Interaction of Docetaxel (“Taxotere”) with Human P‐Glycoprotein
por: Shirakawa, Katsuro, et al.
Publicado: (1999) -
Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere)
por: Wang, G-S, et al.
Publicado: (2001) -
Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells
por: Li, Yiwei, et al.
Publicado: (2005) -
Acute Respiratory Distress Syndrome and COVID-19: A Literature Review
por: Hussain, Musaddique, et al.
Publicado: (2021) -
Sequential or alternating administration of docetaxel (Taxotere®) combined with FEC in metastatic breast cancer: a randomised phase II trial
por: Spielmann, M, et al.
Publicado: (2002)